What cannabis users should know about anti-doping rules

[When treatment has anti-doping implications: therapeutic use exemptions in primary care].

Semergen β€’ β€’ Review β€’ Related
πŸ€–

AI Summary

Therapeutic use exemptions (TUEs) can allow athletes to use otherwise prohibited medicines when there is a justified medical need and anti-doping requirements are met. The article emphasizes that these rules matter beyond elite sport, because family physicians may treat athletes in organized competitions or people subject to testing. It highlights medicines such as systemic glucocorticoids, Ξ²2-agonists, beta-blockers, and diuretics as treatments that may require careful review of dose, route, timing, and clinical context.

The abstract also warns that cannabinoids and some cold medicines or decongestants can contribute to unexpected adverse analytical findings. For cannabis users who compete in tested sports, the practical message is to discuss cannabis and other substances openly with a physician, check official anti-doping resources, and avoid assuming that medical use automatically protects against a rule violation. This is a practical guidance article, not a clinical trial, and the abstract reports no quantitative results.

πŸ’‘ Key Findings

1
Therapeutic use exemptions may permit athletes to use prohibited substances when there is a justified medical indication and anti-doping criteria are fulfilled.
High
80%
2
Cannabinoids can contribute to unexpected adverse analytical findings, so cannabis use may have consequences for athletes subject to testing.
Good
75%
3
The article recommends identifying at-risk patients, consulting official anti-doping tools, documenting medical indications, and considering dose, route, timing, and clinical context.
High
80%
4
The abstract reports no quantitative results; its contribution is practical guidance for primary-care clinicians rather than evidence of a treatment effect.
High
95%

πŸ“„ Original Abstract

Therapeutic use exemptions (TUEs) allow athletes to use prohibited substances or methods when there is a justified medical indication and the criteria established by anti-doping regulations are fulfilled. Although TUEs are commonly associated with professional sport, family physicians may care for federated athletes or individuals subject to anti-doping testing at different levels of competition. In primary care, commonly prescribed treatments such as systemic glucocorticoids, β2-agonists, beta-blockers or diuretics may have regulatory implications if the substance used, dosage, route of administration, timing in relation to competition and clinical context are not adequately considered. In addition, substances of abuse, cannabinoids, and some cold remedies and decongestants may lead to unexpected adverse analytical findings. This article provides practical recommendations aimed at identifying patients at risk, using official consultation tools, adequately justifying medical indications and safely managing common situations related to TUEs in daily clinical practice. .

Explore More Research

Stay informed about the latest cannabis science.

Your stash, decoded.